echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Release of the catalogue of chronic diseases drugs in Nantong, Jiangsu Province

    Release of the catalogue of chronic diseases drugs in Nantong, Jiangsu Province

    • Last Update: 2019-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Just now, a list of medicines for comprehensive prevention and control of chronic diseases in primary medical institutions has been released A variety of commonly used medicines have been selected, most of which are basic medicines In order to promote the construction of national chronic disease comprehensive prevention and control demonstration area, adapt to the requirements of hierarchical diagnosis and treatment, family doctor signing service, and promote the high-quality development of grass-roots health services, Nantong City, Jiangsu Province today released the catalogue of chronic disease comprehensive prevention and control drugs for grassroots medical institutions in Nantong City (Trial) It is reported that the directory contains the medication directory of five common chronic diseases: hypertension, diabetes, COPD, osteoporosis and stroke It has been declared by basic medical institutions, recommended by superior hospitals, reviewed by experts and publicized The catalogue is both practical and authoritative, which provides great convenience for basic medical institutions engaged in chronic disease management services Xiaoshe has comprehensively sorted out the drug catalogue of five kinds of chronic diseases, and found that the vast majority of them are varieties in the basic drug catalogue, which is of great clinical reference value and is worthy of reference by relevant departments around the country Alisartan ester tablets, bisoprolol fumarate tablets, amlodipine besylate tablets, captopril tablets, hydrochlorothiazide tablets, indapamide tablets, potassium losartan tablets, enalapril maleate tablets, irbesartan tablets, irbesartan hydrochlorothiazide tablets, valsartan tablets, valsartan capsules, fosinopril sodium tablets, lisinopril tablets, benazepril hydrochloride tablets, olmesartan ester tablets, candesar Tanoate tablets, terazosin hydrochloride capsules, terazosin hydrochloride tablets, metoprolol tartrate tablets Metformin hydrochloride sustained release tablets, metformin hydrochloride tablets, glimepiride tablets, Acarbose Tablets, acarbose capsules, repaglinide tablets, shagliptin tablets, cigliptin phosphate tablets, recombinant human insulin, insulin glargine, Xiaoke pills, Shenqi Jiangtang Ambroxol hydrochloride tablets, ambroxol hydrochloride injection, acetylcysteine granules, acetylcysteine solution for inhalation, salbutamol sulfate solution for inhalation, compound ipratropium bromide solution for inhalation, compound ipratropium bromide solution for inhalation, budesonide, budesonide, formoterol, fordostan, bromhexin hydrochloride, montelukast sodium tablets, montelukast sodium chewing Tablet, aminophylline tablet, Jinshuibao, compound liquorice, Xingbei Zhike granules Clopidogrel bisulfate tablets, atorvastatin calcium tablets, rosuvastatin calcium tablets, pivastatin calcium tablets, tegrarol tablets, urokinase for injection, warfarin sodium tablets, aspirin enteric coated tablets, recombinant human tissue plasminogen kinase derivatives, anencephalin tablets (pills), nimodipine Alfacalcohol tablet, alfacalcohol soft capsule, alendronate sodium tablet, calcium gluconate tablet, calcium gluconate injection, Xianling Gubao capsule, jintange capsule, Gushukang capsule, calcium carbonate D3 tablet List of detailed contents attached:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.